Mutations in the TET2 gene are frequently observed in hematological cancers, such as acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and chronic myelomonocytic leukemia [15,16]. This evidence concerns the gene TET2 and myelodysplastic syndrome.